Coping with Metastatic Triple Negative Breast Cancer

Listen Now

Topics Covered

• Updates on the Treatment of Metastatic Triple Negative Breast Cancer, in the Context of COVID-19
• Novel Treatment Approaches
• Clinical Trial Updates
• How Research Offers More Treatment Options
• Diagnostic Testing and Technologies: Why They Are So Important
• The Role of Precision Medicine in Improving Treatment Decisions
• Tips to Cope with & Control Symptoms, Side Effects & Pain
• Guidelines to Prepare for Telehealth/Telemedicine Appointments to Reduce Your Exposure to COVID-19
• Key Questions to Ask Your Health Care Team, including Quality-of-Life Concerns
• Practical Strategies to Cope with Metastatic Triple Negative Breast Cancer
• How to Find the Financial, Emotional & Social Supports to Cope
• Questions for Our Panel of Experts

Our Panel of Experts

Generosa Grana, MD, FACP

Medical Director, MD Anderson Cancer Center at Cooper, Division Head, Hematology & Medical Oncology, The Cooper Health System, Professor of Medicine, Cooper Medical School at Rowan University

Sara M. Tolaney, MD, MPH

Associate Director, Susan F. Smith Center for Women’s Cancers, Associate Director, Clinical Research, Breast Oncology, Senior Physician, Dana-Farber Cancer Institute, Assistant Professor of Medicine, Harvard Medical School

Hayley Dinerman, JD

Co-Founder and Executive Director, Triple Negative Breast Cancer Foundation^®

Lauren Chatalian, MSW

Women and Children’s Program Manager, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on October 14, 2020.